Cargando…

Relevant Cytokines in the B Cell Lymphoma Micro-Environment

Cytokines are soluble protein factors with importance in intercellular communication and, as such, play pivotal roles in the pathogenesis of B cell malignancies. Evidence from in vitro cultures permitted us to choose example cytokines that bind to different biochemical receptor types. Activated mali...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krause, Günter, Hassenrück, Floyd, Hallek, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564074/ https://www.ncbi.nlm.nih.gov/pubmed/32899476 http://dx.doi.org/10.3390/cancers12092525

Ejemplares similares

Copanlisib for treatment of B-cell malignancies: the development of a PI3K inhibitor with considerable differences to idelalisib
por: Krause, Günter, et al.
Publicado: (2018)

Sensitive Detection of the Natural Killer Cell-Mediated Cytotoxicity of Anti-CD20 Antibodies and Its Impairment by B-Cell Receptor Pathway Inhibitors
por: Hassenrück, Floyd, et al.
Publicado: (2018)

Cytokines and direct cell contact in synovitis: relevance to therapeutic intervention
por: Dayer, Jean-Michel, et al.
Publicado: (1999)

Making microbiology of the built environment relevant to design
por: Brown, G. Z., et al.
Publicado: (2016)

Functional impact and molecular binding modes of drugs that target the PI3K isoform p110δ
por: Hassenrück, Floyd, et al.
Publicado: (2023)

Single‐cell profiling guided combination therapy of c‐Fos and histone deacetylase inhibitors in diffuse large B‐cell lymphoma
por: Krämer, Oliver H., et al.
Publicado: (2022)

Presence of Viral microRNA in Extracellular Environments
por: DeMarino, Catherine, et al.
Publicado: (2017)

The race is on: bispecifics vs CAR T cells in B-cell lymphoma
por: Gurumurthi, Ashwath, et al.
Publicado: (2023)

Advances in Polatuzumab Vedotin-PIIQ Therapy: A Review of Treatment Efficacy in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma
por: Abdur Raqib, Moosa, et al.
Publicado: (2023)

Targetable Metabolic Vulnerability in Diffuse Large B-Cell Lymphoma
por: Xiong, Jie, et al.
Publicado: (2018)

The Search for Surrogate Endpoints in Trials in Diffuse Large B‐Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project
por: Sargent, Daniel J., et al.
Publicado: (2017)

Implications of Contact Days in the Treatment of Relapsed Refractory Diffuse Large B-Cell Lymphoma
por: Bojanini, Leyla, et al.
Publicado: (2023)

Peripheral T cell lymphoma
por: Patel, Moosa
Publicado: (2018)

United we stand: Double targeting of CD79B and CD20 in diffuse large B‐cell lymphoma
por: Tarantelli, Chiara, et al.
Publicado: (2022)

Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma
por: Jaeger, Ulrich, et al.
Publicado: (2022)

Paving the path to better understanding T-cell lymphomas: The importance of lymphoma registries
por: Malpica, Luis
Publicado: (2021)

Endoscopic Findings of Gastric Extranodal Marginal Zone B-Cell Mucosa-Associated Lymphoid Tissue Lymphoma
por: Lee, Sang Kil
Publicado: (2017)

Hodgkin lymphoma: flow me?
por: Beaty, Michael W, et al.
Publicado: (2005)

Anaplastic large cell lymphoma: The evolution continues
por: Das, Dilip K
Publicado: (2011)

Relevance of chemistry to white biotechnology
por: Gupta, Munishwar N, et al.
Publicado: (2007)

Macrolide resistance in pneumococci—is it relevant?
por: Cheng, Allen C., et al.
Publicado: (2016)

Update on checkpoint blockade therapy for lymphoma
por: Kline, Justin, et al.
Publicado: (2015)

Are all cytokine storms the same?
por: Panoskaltsis, Nicki
Publicado: (2021)

A follow-up to "Anti-cytokine therapy in chronic destructive arthritis" by Wim B van den Berg
por: Brennan, Fionula M
Publicado: (2001)

Do we have to exclude all relapsed diffuse large B‐cell lymphoma patients not in complete remission from autologous stem cell transplant?
por: Gisselbrecht, Christian, et al.
Publicado: (2022)

Peripheral T cell lymphoma: new model + new insight
por: Mulloy, James C.
Publicado: (2010)

microRNA profiling in Epstein–Barr virus-associated B-cell lymphoma
por: Imig, Jochen, et al.
Publicado: (2011)

MicroRNA-142 is mutated in about 20% of diffuse large B-cell lymphoma
por: Kwanhian, Wiyada, et al.
Publicado: (2012)

Inclusion, Measurement and Relevance… and Covid-19
por: Traxler, John
Publicado: (2020)

Is Insulin Action in the Brain Clinically Relevant?
por: Filippi, Beatrice M., et al.
Publicado: (2012)

Decreased Naïve T-cell Production Leading to Cytokine Storm as Cause of Increased COVID-19 Severity with Comorbidities
por: Schwartz, Michael D, et al.
Publicado: (2020)

NF-κB signaling and its relevance to the treatment of mantle cell lymphoma
por: Balaji, Swathi, et al.
Publicado: (2018)

Hypothesis on the possible relevance of the immunogenic cell death in the treatment of gestational trophoblastic neoplasms
por: Frega, G., et al.
Publicado: (2021)

MicroRNA signatures in B-cell lymphomas
por: Di Lisio, L, et al.
Publicado: (2012)

MicroRNAs as Biomarkers of B-cell Lymphoma
por: Solé, Carla, et al.
Publicado: (2018)

Cytokine Storms in Cancer and COVID-19
por: Turnquist, Casmir, et al.
Publicado: (2020)

Unwrapping Neurotrophic Cytokines and Histone Modification
por: Roe, Cieron
Publicado: (2016)

Cytokine Targeted Therapy for Dupuytren's Disease
por: Satish, Latha
Publicado: (2018)

Role of MicroRNA in Pancreatic β-Cells: Where More Is Less
por: Walker, Michael D.
Publicado: (2008)

The relevance of non-human primate and rodent malaria models for humans
por: Langhorne, Jean, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_vufhltjespgad6bkev1c828rtr